India's Infosys falls after cutting revenue growth forecast for fiscal 2027

Infosys shares fell 2.7% after cutting its fiscal 2027 revenue growth forecast to 1%-2% from 1.5%-3%, citing pricing pressure and weak tech spending. Analysts reduced price targets, with the average rating remaining 'Buy' and a median target of 1,180 rupees.

Original reporting
Published Oct 26, 2026, 4:10 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 26, 2026, 4:56 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$INFY
Bearish
high confidence
Mentioned
$INFY
Relevance
7/10
AlphAI data visualization · based on centraloregondaily.com
Decision brief

The 30-second read

$INFYBearishHigh
01

Why it matters

The downgrade triggered a 2.7% share decline and pressured the sector index, highlighting sensitivity to guidance in the IT space.

02

Market read

Guidance cut is a primary catalyst for short‑term price movement and may influence peer valuations.

03

What to watch

Potential cost‑saving measures and margin stability could mitigate earnings impact.

Relevance 7/10Novelty 8/10Timing: pre‑market today

Background

Infosys, a leading Indian IT services provider, reported weaker North America demand and trimmed its growth outlook.

Company-level read

Ticker impact

$INFYBearishHigh confidence
Context

Infosys cut its fiscal 2027 revenue growth forecast to 1%-2% and shares fell 2.7% in early trading.

Expected impact

likely pressure as the market prices in weaker growth expectations

Evidence & confidence

Guidance cuts are a direct catalyst for short-term price declines; the stock already dropped on the news.

Market effects

May weigh on other Indian IT firms as investors reassess growth outlooks.

Contributes to a modest dip in the Nifty IT index.

Limited to emerging‑market tech exposure; minimal impact on broader global indices.

Counterpoint

If the cut is modest and AI revenue picks up, the stock could rebound on longer‑term upside.

Key entities

  • Infosys

    Indian IT services firm

Related articles

$INFYMedAI 8/10

Infosys vs TCS: Which IT stock offers better value after Q2? Deal wins, AI growth in focus

Infosys (INFY) and TCS (TCS) reported Q2 earnings, with Infosys lowering FY27 revenue growth guidance to 1-2% and TCS maintaining stable margins at 24.0%. Infosys reported $5.2B in large-deal TCV, while TCS recorded $9.6B in deal bookings. Both companies highlighted AI revenue growth, with Infosys at 10.5% of total revenue and TCS at $3.1B annualized. Jefferies noted challenges for both, including Infosys' soft growth outlook and TCS' cost pressures.

$INFYMedAI 8/10

Infosys Share Price: Should You Buy, Sell or Hold After Q2 Results? Here’s What Brokerage has to Say

Infosys Ltd (market cap: Rs 4,60,919 crore) reported Q2 FY27 revenue growth of 1.2% QoQ, missing estimates. Brokerages like UBS, Nomura, HSBC, Goldman Sachs, and Citi have mixed outlooks, with target prices ranging from Rs 1,000 to Rs 1,415. The company cut FY27 revenue growth guidance to 1-2% YoY, citing demand challenges. Infosys' share price was Rs 1,136, down 1.62% from the previous close, with a 25% negative return over the last year.

$INFYHighAI 8/10

Infosys shares fall 4% after FY27 revenue growth guidance cut

Infosys shares dropped 4% after cutting FY27 revenue growth guidance to 1-2% from 1.5-3% due to sluggish client spending. Q2 revenue was ₹49,244 crore, up 1.5% y-o-y, with net profit increasing 6.2%. Goldman Sachs and Citi noted subdued demand and maintained neutral ratings with target prices of ₹1,000 and ₹1,105, respectively.

$INFYHighAI 8/10

Why is Infosys stock falling today?

Infosys (INFY) shares fell 1.5% after lowering its full-year revenue growth forecast to 1%–2% from 1.5%–3%, citing slower project volumes and pricing pressure. UBS cut its price target to ₹1,415 from ₹1,430, maintaining a Buy rating. Q2 revenue growth and EBIT margin missed expectations.